Litcius/Paper detail

Elafibranor: First Approval

Hannah A. Blair

2024Drugs23 citationsDOI

Topics & Concepts

Ursodeoxycholic acidMedicineAlkaline phosphataseInternal medicinePrimary sclerosing cholangitisObeticholic acidAgonistDrug approvalPharmacotherapyPeroxisome proliferatorGastroenterologyPharmacologyDrugPeroxisome proliferator-activated receptorReceptorDiseaseBiochemistryChemistryEnzymeLiver Diseases and ImmunityCholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and Treatments
Elafibranor: First Approval | Litcius